Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aihua Zhuang
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0009-0005-1442-6795
Observed ORCID:
0009-0005-1442-6795
OpenAlex ID:
A5137548019
Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
·
Clinical Cancer Research
·
4
Visualization Exploration and Application Effect of Drug Configuration Process Based on Daytime Chemotherapy Interaction Design Information System
2026
·
Fan Yang
, Yufeng Pan
, et al.
·
JOURNAL OF MEDICINES DEVELOPMENT SCIENCES
Supplementary Data S1 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Figure S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Data from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Table S2 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Table S3 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Figure S2 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Figure S1 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Supplementary Table S1 from Phase III Trial of Pegylated Liposomal Doxorubicin for Patients with Advanced and Refractory Desmoid Tumors
2026
·
Huaiyuan Xu
, Jinxin Hu
, et al.
Show more works
View as search
Works count:
10
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type